Latest news
Unseen allies: symbiotic bacteria help clean wastewater, but there is a catch
Scientists have identified new species of denitrifying endosymbionts in wastewater, highlighting their global prevalence – with an unexpected climate implication.
Gut bacteria from amphibians and reptiles achieve complete tumor elimination
Researchers have discovered that the bacterium Ewingella americana, isolated from the intestines of Japanese tree frogs (Dryophytes japonicus), possesses remarkably potent anticancer activity.
Hidden viruses in wastewater treatment may shape public health risks, study finds
A new study reveals that viral communities in wastewater treatment plants are far more complex and influential than previously recognized, with implications for water safety, antibiotic resistance, and how treatment performance is monitored.
Who is more likely to get long COVID?
Scientists have identified the key genetic drivers behind long COVID, revealing why some people continue to experience debilitating symptoms long after their initial infection.
Study uncovers new drug target for huge class of viruses
A study reveals how enteroviruses—including pathogens that cause polio, encephalitis, myocarditis, and the common cold—initiate replication by hijacking host-cell machinery.
A fatal mix-up: How certain gut bacteria drive multiple sclerosis
If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to attack its own nervous system. This mechanism can accelerate the progression of multiple sclerosis.
Unseen allies: symbiotic bacteria help clean wastewater, but there is a catch
Scientists have identified new species of denitrifying endosymbionts in wastewater, highlighting their global prevalence – with an unexpected climate implication.
Gut bacteria from amphibians and reptiles achieve complete tumor elimination
Researchers have discovered that the bacterium Ewingella americana, isolated from the intestines of Japanese tree frogs (Dryophytes japonicus), possesses remarkably potent anticancer activity.
Hidden viruses in wastewater treatment may shape public health risks, study finds
A new study reveals that viral communities in wastewater treatment plants are far more complex and influential than previously recognized, with implications for water safety, antibiotic resistance, and how treatment performance is monitored.
Strategic advancement of second-generation fungal vaccine VXV-01 through Phase 1 trials
The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) have announced that the second-generation fungal vaccine candidate known as VXV‑01 is poised to move forward in development up to and including Phase 1 clinical evaluation.
CARB-X to support investigation of Exhalon’s breath-based lower respiratory tract infection testing platform
CARB-X has awarded Exhalon US$1M in seed funding to evaluate whether exhaled breath can be used as a non-invasive sample type to aid in the rapid and accurate diagnosis of lower-respiratory tract infections (LRTIs).
AFYREN and ESSE Skincare begin partnership to offer 100% natural cosmetic solutions with enhanced skincare performance
AFYREN, a greentech company offering manufacturers biobased, low-carbon ingredients through a unique fermentation technology, and South Africa-based Esse Skincare, a leader in microbiome skincare science, are partnering to introduce the world’s first bio-based propionic acid for the skincare industry.
Mutated baker’s yeast at the forefront of petroleum substitute tech
Researchers engineering Saccharomyces cerevisiae to produce 2,3-butanediol (2,3-BDO) introduced mutations into the genomic DNA. The researchers engineered four altered strains and subjected them to ethanol, heat, and low pH stressors.
Smarter tools for peering into the microscopic world
In a pair of new studies, researchers introduce powerful tools that make it easier, more accurate and more scalable to figure out how microbes are related. One tool improves how scientists build microbial family trees. The other provides a software foundation used worldwide to analyze biological data.
Bacteria double as Trojan horse for artificial amino acids
Researchers have hijacked a natural transport system of the bacterium E. coli to develop a solution that allows artificial amino acids to be introduced into bacteria efficiently. This means the “amino acid toolbox” can be expanded for widespread use in medicine and the biotech industry.
Global Virus Network announces appointment of new board members
The Global Virus Network (GVN), a worldwide coalition of leading human and animal virologists, has announced the appointment of eight distinguished leaders to its Board of Directors.
How can nursing homes protect more patients from infections?
New US national guidance calls for full-time infection prevention staff; more training, support and vaccination for all staff; and partnerships with hospitals and public health agencies.
What are the new guidelines for infant hepatitis B vaccination?
Public health expert and infectious disease physician Janet A. Jokela comments after the Advisory Committee on Immunization Practices of the CDC voted to discontinue its decades-long recommendation for universal vaccination against hepatitis B beginning at birth.